[SRNE] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
06-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -8.08%
YoY- -30.44%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 13,511 14,255 11,505 11,753 9,007 7,721 13,034 2.42%
PBT -167,340 2,212 -73,068 -86,398 -82,213 -68,900 -69,110 80.41%
Tax -641 -206 36 145 -1,919 -276 309 -
NP -166,615 2,510 -71,502 -84,023 -77,740 -65,195 -62,820 91.72%
Tax Rate - 9.31% - - - - - -
Total Cost 180,126 11,745 83,007 95,776 86,747 72,916 75,854 78.08%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -1,233.18 17.61 -621.49 -714.91 -863.11 -844.39 -481.97 87.17%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -0.57 0.01 -0.28 -0.33 -0.36 -0.36 -0.34 41.16%
EPS Diluted -0.57 0.01 -0.28 -0.33 -0.36 -0.36 -0.34 41.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.